PSAT1 and prostate carcinoma: Analysis of a large number (>8000) prostate cancer patients allowed defining the clinicopathologic features of SPOP-mutant tumors: lower frequency of positive margins, extra prostatic extension, and seminal vesicle invasion at prostatectomy; higher pretreatment serum PSA levels [133].